Literature DB >> 24961839

The impact of computed tomographic screening for lung cancer on the thoracic surgery workforce.

Janet P Edwards1, Indraneel Datta2, John Douglas Hunt3, Kevin Stefan4, Chad G Ball2, Elijah Dixon2, Sean C Grondin5.   

Abstract

BACKGROUND: This study aimed to predict variation in the thoracic surgery workforce requirements with the introduction of a national chest computed tomographic (CT) screening program for individuals at high risk of lung cancer.
METHODS: Using Canadian census microdata and the Canadian Community Health Survey, a microsimulation model representing the national population was developed. The demand component simulates the incidence of lung cancer, whereas the supply component simulates the number of practicing thoracic surgeons. A national CT screening program in high-risk individuals (>30 pack-year history of smoking; age, 55-74 years) was introduced into the model to predict changes in the number of operable lung cancers per thoracic surgeon.
RESULTS: From 2013 to 2040, the Canadian population increased from 34 to 43 million. The number eligible for screening varies from 1,112,800 (2013) to 513,200 (2040), peaking at 1,147,700 (2017). Comparing CT screening with chest radiography, overall lung cancer diagnoses increase 7.3% by 2040, with stage 1A increasing by 15.6% and stage IV decreasing by 7.5%. The rate of operable early lung cancers per thoracic surgeon increases by 24.2% (2020), 19.8% (2030), and 16% (2040), with CT screening relative to the baseline increase seen with chest radiography.
CONCLUSIONS: With the implementation of a CT screening program there will be an increase in operable lung cancers, resulting in increased surgical volume. A national strategy for the thoracic surgery workforce is necessary to ensure that an appropriate number of surgeons are being trained to meet the future needs of the national population.
Copyright © 2014 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24961839     DOI: 10.1016/j.athoracsur.2014.04.076

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

Review 1.  Lung Cancer Screening.

Authors:  Richard M Hoffman; Rolando Sanchez
Journal:  Med Clin North Am       Date:  2017-07       Impact factor: 5.456

2.  Impact of low-dose computed tomography for lung cancer screening on lung cancer surgical volume: The urgent need in health workforce education and training.

Authors:  Yi-Chi Hung; En-Kuei Tang; Yun-Ju Wu; Chen-Jung Chang; Fu-Zong Wu
Journal:  Medicine (Baltimore)       Date:  2021-08-13       Impact factor: 1.817

3.  Development and validation of nomogram estimating post-surgery hospital stay of lung cancer patients: relevance for predictive, preventive, and personalized healthcare strategies.

Authors:  Xiang-Lin Hu; Song-Tao Xu; Xiao-Cen Wang; Jin-Long Luo; Dong-Ni Hou; Xiao-Min Zhang; Chen Bao; Dong Yang; Yuan-Lin Song; Chun-Xue Bai
Journal:  EPMA J       Date:  2019-05-08       Impact factor: 6.543

4.  Prevalence of and risk factors for presenting initial respiratory symptoms in patients undergoing surgery for lung cancer.

Authors:  Xiang-Lin Hu; Song-Tao Xu; Xiao-Cen Wang; Dong-Ni Hou; Cui-Cui Chen; Yuan-Lin Song; Dong Yang
Journal:  J Cancer       Date:  2018-08-31       Impact factor: 4.207

5.  Treatment capacity required for full-scale implementation of lung cancer screening in the United States.

Authors:  Erik F Blom; Kevin Ten Haaf; Douglas A Arenberg; Harry J de Koning
Journal:  Cancer       Date:  2019-02-27       Impact factor: 6.860

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.